What will TrumpRx mean for patients? Who saves — and how much
Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer…
AstraZeneca to list shares in New York while keeping London listing
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Investors of India’s generic drugmakers rattled
MUMBAI, INDIA – MARCH 3: A technician works at a Cipla laboratory March 3, 2002 in Vikhrohi, Mumbai,…
Natural Plant Compound Shows Promise for Treating Gum Disease
A natural compound called morin, found in fruits, teas, and nuts, is showing promise as a new tool…
EU Panel Recommends Tezspire for CRwNP | RT
AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult…
Study Finds Common Meds Leave Lasting Imprints on the Gut, Even Years After You Stop Taking Them
Medications may leave microbial “fingerprints” that last years after use, according to new research from the University of…
Chemical Discovery Could Lower Prescription Drug Costs
A new sustainable method to produce pharmaceuticals could help to lower prescription drug costs in the U.S. This…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
UK’s GSK announces $30 billion U.S. pharma investment amid Trump state visit
Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…